Liberty Star issues $137,500 convertible note to Labrys Fund II LP

LIBERTY STAR URANIUM & METALS CORP.

Principal amount $137,500 with 10% original issue discount, net proceeds ~$123,750.
Note bears 8% interest, matures one year from August 7, 2025.
Outstanding principal and interest convertible into common stock at terms in the note.
Securities Purchase Agreement filed as Exhibits 3.63 and 3.64.
Financing used for general corporate purposes; dilution risk from conversion.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 1.0

LIBERTY STAR URANIUM & METALS CORP. incurred convertible notes of $137,500 with Labrys Fund II LP at 8% maturing one year from date of Agreement.

Instrument: convertible notes
Principal: $137,500
Counterparty: Labrys Fund II LP
Rate: 8%
Maturity: one year from date of Agreement
Event: incurrence

Exact text from the filing

On August 11, 2025, Liberty Star Uranium & Metals Corp. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with Labrys Fund II LP. (“Labrys II”). Pursuant to the terms of the Securities Purchase Agreement, the Company agreed to issue a convertible promissory note (the “Note”) to Labrys II in the principal amount of $137,500 which includes an original issue discount of 10% (the “OID”). Effective August 7, 2025, the Company issued a Note to Labrys II consistent with the terms of the Securities Purchase Agreement. The Note bears interest at 8% and matures in one year from date of Agreement.

View on SEC.gov

306 debt financings filed in the last 30 days. Browse all debt financings →

LIBERTY STAR URANIUM & METALS CORP. filing history →

Source: SEC EDGAR

accession 0001493152-25-011869

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.